Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Preparis unveils new website to help businesses and employees prepare for swine flu pandemic

Preparis, Inc. today associated the rapid spread of H1N1 pandemic to the high percentage of companies that are not doing enough to prevent its spread in the workplace. In response, the company has unveiled a special website dedicated to helping businesses and their employees prepare for the “swine flu” pandemic. This free service, called H1N1 Central, takes a decidedly business-centric and hands-on approach. It can be found at www.preparis.com.

6 Nov 2009

New findings may lead to novel therapeutic approaches for HIV and prostate cancer

New Haven, Conn.-Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

6 Nov 2009

School district leaders plan for H1N1 pandemics using a four-step process

School district leaders planning for H1N1 pandemics should update emergency plans using a four-step process, according to the McGraw-Hill Education Urban Advisory Resource, a team of former educators and school administrators dedicated to serving the unique needs of large school districts.

6 Nov 2009

GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines

GenVec, Inc, announced today that SAIC-Frederick, Inc. has signed a contract with GenVec for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

5 Nov 2009

U.S. health officials offer no prediction of when all high-risk groups will have access to H1N1 vaccine

U.S. health officials briefing Congress on Wednesday would not outline a timeline for when enough H1N1 (swine flu) vaccines would be available to reach all high-risk populations in the country, the Washington Post reports.

5 Nov 2009

Japanese data suggests a protocol for schools to follow during H1N! pandemic

As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down? A study led by epidemiologists John Brownstein, PhD, and Anne Gatewood Hoen, PhD of the Children's Hospital Boston Informatics Program, in collaboration Asami Sasaki of the University of Niigata Prefecture (Niigata, Japan), tapped a detailed set of Japanese data to help guide decision making by schools and government agencies.

5 Nov 2009

SafetyTies and SafetyScarves of SafeSmart help reduce the spread of H1N1

According to the Centers for Disease Control (CDC), H1N1 - better known as the swine flu - was widespread in 48 states as of Oct. 18-24. The CDC's website offers guidelines, from cough etiquette to keeping sick workers at home, for healthcare professionals and the public on how to minimize spread of the H1N1 influenza.

5 Nov 2009

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

The World Health Organization recently declared H1N1 swine flu a global pandemic, resulting in the creation of rigorous vaccination programs worldwide. Children are among those considered particularly susceptible to contracting swine flu and are viewed as a top priority in receiving this vaccine.

5 Nov 2009

Healthcare unions in Nova Scotia to suspend all collective activities till New Year in response to H1N1 flu

Three of the four major healthcare unions in Nova Scotia have agreed to suspend all collective bargaining activities until at least the New Year. This move is in response to the increased pressures that the H1N1 flu pandemic is placing on the province's health system.

5 Nov 2009

One Health Commission summit to focus on emerging infectious diseases

The growing threat of the H1N1 pandemic and West Nile virus -- as well as other emerging zoonotic, food, or waterborne diseases and environmental changes -- has prompted experts to look for solutions to the increasingly integrated problems among animal, human, and environmental health.

5 Nov 2009

Department of Health urges healthcare professionals to be vaccinated against H1N1 flu

Saying healthcare workers are "on the front lines" of battling the H1N1 flu pandemic, the Department of Health today urged healthcare professionals across Pennsylvania to be vaccinated against the H1N1 flu.

4 Nov 2009

News outlets examine international efforts to contain H1N1

A WHO official on Tuesday backed the Afghan government's decision to declare H1N1 (swine flu) a health emergency, forcing the closure of all schools in the country for three weeks in an effort to contain the virus, IRIN reports.

4 Nov 2009

Shionogi files New Drug Application in Japan

BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.

4 Nov 2009

BD reports revenues of $1.898 billion for the fourth quarter of 2009

BD (Becton, Dickinson and Company) today reported quarterly revenues of $1.898 billion for the fourth fiscal quarter ended September 30, 2009, representing an increase of 5 percent from the prior-year period, or 8 percent excluding the unfavorable impact from foreign currency translation.

From BD (Becton, Dickinson and Company) 4 Nov 2009

Hospitalization and death of H1N1 patients can occur at all ages, says study

In contrast with some common perceptions regarding 2009 influenza A(H1N1) infections, an examination of cases in California indicates that hospitalization and death can occur at all ages, and about 30 percent of hospitalized cases have been severe enough to require treatment in an intensive care unit, according to a study in the November 4 issue of JAMA.

4 Nov 2009

Five-year old Pennsylvanian boy dies of H1N1 flu complications

The Department of Health today confirmed that a five-year old Adams County boy died on Oct. 31 as a result of complications from H1N1 flu. This is Pennsylvania's first pediatric death associated with H1N1.

4 Nov 2009

Fear of flu pandemic triggers fear of unrelated health hazards: Study

The swine flu (H1N1) pandemic has received extensive media coverage this year. The World Health Organization, in addition to providing frequent updates about cases of infection and death tolls, recommends hyper vigilance in daily hygiene such as frequent hand washing or sneezing into the crook of our arms. News reports at all levels, from local school closures to airport screenings and global disease surveillance, continue to remind us of the high risk.

4 Nov 2009

Report: Pandemic flu threat influences vaccine market to expand rapidly

MarketResearch.com has announced the addition of Datamonitor's new report "Seasonal Influenza Vaccines Market Forecast," to their collection of Healthcare market reports.

4 Nov 2009

Aetna provides free electronic roster billing to pharmacies and other providers for H1N1 flu vaccine claims

Aetna is providing free electronic roster billing for pharmacies and other non-traditional providers to use when submitting claims for the administration of the H1N1 flu vaccine.

4 Nov 2009

Aethlon Medical begins collaborative biomarker program to study neurodegenerative disease

Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that it has initiated a collaborative biomarker discovery program with the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine and the Sports Legacy Institute (SLI).

3 Nov 2009

Pandemic News and Research

Further Reading

Preparis unveils new website to help businesses and employees prepare for swine flu pandemic

New findings may lead to novel therapeutic approaches for HIV and prostate cancer

School district leaders plan for H1N1 pandemics using a four-step process

GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines

U.S. health officials offer no prediction of when all high-risk groups will have access to H1N1 vaccine

Japanese data suggests a protocol for schools to follow during H1N! pandemic

SafetyTies and SafetyScarves of SafeSmart help reduce the spread of H1N1

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

Healthcare unions in Nova Scotia to suspend all collective activities till New Year in response to H1N1 flu

One Health Commission summit to focus on emerging infectious diseases

Department of Health urges healthcare professionals to be vaccinated against H1N1 flu

News outlets examine international efforts to contain H1N1

Shionogi files New Drug Application in Japan

BD reports revenues of $1.898 billion for the fourth quarter of 2009

Hospitalization and death of H1N1 patients can occur at all ages, says study

Five-year old Pennsylvanian boy dies of H1N1 flu complications

Fear of flu pandemic triggers fear of unrelated health hazards: Study

Report: Pandemic flu threat influences vaccine market to expand rapidly

Aetna provides free electronic roster billing to pharmacies and other providers for H1N1 flu vaccine claims

Aethlon Medical begins collaborative biomarker program to study neurodegenerative disease

Best practices - optimize qPCR processes for pathogen detection eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News